Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

US Patent 11572413 · Granted Feb 7, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2025
Methods and compositions for targeting Treg cells2024
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2024
Monoclonal antibody neo-201 for the treatment of human carcinomas2023
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2023
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2022
Development of agonist epitopes of the human papillomavirus2022